KPV Reconstitution Guide
Part of the full KPV guide - a melanocortin-derived c-terminal tripeptide reference compound, identity-verified with a COA on every vial.
In brief
This spoke covers laboratory reconstitution of KPV for in-vitro handling only. KPV is supplied as a lyophilized (freeze-dried) powder that must be brought into solution before it can be dispensed in cell-based or microbial assays of the kind described in the cited literature. The standard laboratory diluent for this purpose is bacteriostatic water, which contains a small amount of benzyl alcohol to limit microbial growth across repeated withdrawals from a multi-use vial. The objective of reconstitution is twofold: to fully dissolve the powder without degrading the peptide, and to produce a defined stock concentration so that downstream dilution math, for nanomolar working concentrations like those reported in the in-vitro signaling work, is reproducible. Given KPV's molecular weight of 342.43 g/mol, its small tripeptide size makes molar concentration calculations straightforward. Nothing here describes human dosing; every step below is a bench-preparation procedure for research material destined for in-vitro experiments.
The detail
A closer look
01
Concentration math from molecular weight
With a molecular weight of 342.43 g/mol, KPV's stock molarity follows directly from the mass dissolved and the diluent volume. As a worked example, reconstituting a 5 mg vial in 2 mL of bacteriostatic water yields 2.5 mg/mL. Converting to molarity, 2.5 mg/mL divided by 342.43 g/mol gives roughly 7.3 mM stock. Because the cited in-vitro signaling effects are reported at nanomolar concentrations, that millimolar stock provides ample headroom for serial dilution into assay media down to the working range. Researchers typically pick a reconstitution volume that makes their target working concentration land on convenient dilution factors. Always confirm the exact vial mass on the certificate of analysis, since fill mass, not assumed mass, governs the true concentration.
02
Stability and storage handling
As a small lyophilized tripeptide, KPV is generally most stable in its dry, freeze-dried state, so vials are best kept sealed and cold until reconstitution. Once dissolved, peptide solutions are more labile and are typically held refrigerated for near-term use and frozen for longer-term storage, with repeated freeze-thaw cycles minimized to preserve integrity. The benzyl alcohol in bacteriostatic water supports multiple sterile withdrawals from a single vial over a working window. These are general peptide-handling practices; the entry does not provide a KPV-specific measured shelf life or degradation rate, so exact stability limits for a given preparation should be established empirically and documented per laboratory protocol.
Step by step
How KPV is reconstituted
A bench reference for handling and preparation in an in-vitro research setting. Not a personal dosing protocol.
- 1
Confirm the labeled peptide mass on the vial certificate of analysis and let the sealed vial equilibrate toward room temperature to reduce condensation.
- 2
Select a reconstitution volume of bacteriostatic water that yields a convenient stock concentration for your planned serial dilutions (e.g., 2 mL for a 5 mg vial = 2.5 mg/mL).
- 3
Add the bacteriostatic water slowly down the inner vial wall rather than directly onto the powder, to avoid foaming and localized denaturation.
- 4
Do not shake; gently swirl or roll the vial until the lyophilized powder is fully dissolved and the solution is clear.
- 5
Calculate the resulting molar stock concentration using MW 342.43 g/mol (mass in mg/mL divided by 342.43 to get mM).
- 6
Label the vial with concentration, diluent, and date, then store refrigerated for near-term in-vitro use or frozen for longer-term storage, minimizing freeze-thaw cycles.
- 7
Serially dilute the stock into assay medium to reach nanomolar-range working concentrations for cell-based or microbial in-vitro experiments.
The fine print: products are sold for laboratory research use only and are not for human or animal consumption. Bodily introduction into humans or animals is strictly prohibited by law. KPV is not a drug and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA.